Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 273

1.

Human vaccine research in the European Union.

Olesen OF, Lonnroth A, Mulligan B.

Vaccine. 2009 Jan 29;27(5):640-5. doi: 10.1016/j.vaccine.2008.11.064. Epub 2008 Dec 6. Review.

PMID:
19059446
2.

Tuberculosis research in the European union: past achievements and future challenges.

Lång H, Quaglio G, Olesen OF.

Tuberculosis (Edinb). 2010 Jan;90(1):1-6. doi: 10.1016/j.tube.2009.10.002. Epub 2009 Oct 31.

PMID:
19880350
3.

The European research effort for HIV/AIDS, malaria and tuberculosis.

Medaglini D, Hoeveler A.

Vaccine. 2003 Jun 1;21 Suppl 2:S116-20.

PMID:
12763694
4.

Building collaborative networks for HIV/AIDS vaccine development: the AVIP experience.

Ferrantelli F, Buttò S, Cafaro A, Wahren B, Ensoli B.

Springer Semin Immunopathol. 2006 Nov;28(3):289-301. Epub 2006 Sep 16. Review.

PMID:
16983452
5.

Novel human vaccine strategies and the 5th Framework Programme: pushing the envelope.

Tagliabue A, Cesaroni MP, Lewis DJ.

Vaccine. 2003 Jun 1;21 Suppl 2:S121-7.

PMID:
12763695
6.

European Union research strategies on vaccines.

Hansen B.

Dev Biol Stand. 1997;89:29-36. Review.

PMID:
9272333
7.

European Union and EDCTP strategy in the global context: recommendations for preventive HIV/AIDS vaccines research.

Lehner T, Hoelscher M, Clerici M, Gotch F, Pedneault L, Tartaglia J, Gray C, Mestecky J, Sattentau Q, van de Wijgert J, Toure C, Osmanov S, Schmidt RE, Debre P, Romaris M, Hoeveler A, Di Fabio S.

Vaccine. 2005 Dec 1;23(48-49):5551-6. Epub 2005 Jul 20.

PMID:
16153752
8.

Vaccine adjuvants: a priority for vaccine research.

Harandi AM, Medaglini D, Shattock RJ; Working Group convened by EUROPRISE..

Vaccine. 2010 Mar 11;28(12):2363-6. doi: 10.1016/j.vaccine.2009.12.084. Epub 2010 Jan 9.

PMID:
20064476
9.

Post-genomic challenges for collaborative research in infectious diseases.

Okeke IN, Wain J.

Nat Rev Microbiol. 2008 Nov;6(11):858-64. doi: 10.1038/nrmicro1989. Epub 2008 Aug 19. Review.

PMID:
18711428
10.

[Establishing ophthalmology in the research framework programs of the European Union].

Scholl HP, Wheeler-Schilling TH, Zrenner E, Holz FG.

Ophthalmologe. 2006 Feb;103(2):91-9. Review. German.

PMID:
16437232
11.

European Union vaccine research--an overview.

Sautter J, Olesen OF, Bray J, Draghia-Akli R.

Vaccine. 2011 Sep 9;29(39):6723-7. doi: 10.1016/j.vaccine.2010.12.060. Epub 2010 Dec 31.

PMID:
21195799
12.

The European and developing countries clinical trails partnership.

Olliaro P, Smith PG.

J HIV Ther. 2004 Sep;9(3):53-6. Review.

PMID:
15534561
13.

The global HIV vaccine enterprise.

Esparza J.

Int Microbiol. 2005 Jun;8(2):93-101. Review.

14.

Translational medicine policy issues in infectious disease.

Fears R, van der Meer JW, ter Meulen V.

Sci Transl Med. 2010 Jan 13;2(14):14cm2. doi: 10.1126/scitranslmed.3000375.

PMID:
20371464
16.

Novel vaccines: bridging research, development and production.

Demirjian A, Levy O.

Expert Rev Vaccines. 2008 Nov;7(9):1321-4. doi: 10.1586/14760584.7.9.1321.

PMID:
18980535
17.

Advances in immunology and vaccine discovery report of the United States-European Commission workshop.

Gay CG, Richie TL, Pastoret PP, Minguez-Tudela I, de Baetselier P, Göbel T, Goddeeris B, Kaiser P, Morrison I, Sánchez-Vizcaíno JM, Anderson K, Baillie LW, Brown WC, Estes DM, Herrera E, Nara PL, Ockenhouse CF, Roth JA, Sztein MB.

Vaccine. 2007 Oct 10;25(41):7007-11. Epub 2007 Aug 6.

PMID:
17728022
18.
19.

6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID).

Dinleyici EC, Kurugol Z.

Expert Rev Vaccines. 2010 Mar;9(3):261-72. doi: 10.1586/erv.10.1.

PMID:
20218854
20.

Taking aim at novel vaccines market.

Awasthi S.

Hum Vaccin. 2009 Oct;5(10):654-7. Epub 2009 Oct 1.

PMID:
19855156

Supplemental Content

Support Center